IRF3 Monoklonaler Antikörper

IRF3 Monoklonal Antikörper für WB, IHC, ELISA

Wirt / Isotyp

Maus / IgG1

Getestete Reaktivität

human und mehr (1)

Anwendung

WB, IHC, IF, CoIP, ELISA

Konjugation

Unkonjugiert

Publikationen(16)

CloneNo.

1E6G8

Kat-Nr. : 66670-1-Ig

Synonyme

1E6G8, interferon regulatory factor 3, IRF 3, IRF-3



Geprüfte Anwendungen

Erfolgreiche Detektion in WBHeLa-Zellen, A431-Zellen, Daudi-Zellen, HepG2-Zellen, Jurkat-Zellen, MOLT-4-Zellen, Ramos-Zellen, THP-1-Zellen
Erfolgreiche Detektion in IHChumanes Milzgewebe, humanes Tonsillitisgewebe
Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:5000-1:50000
Immunhistochemie (IHC)IHC : 1:250-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

66670-1-Ig bindet in WB, IHC, IF, CoIP, ELISA IRF3 und zeigt Reaktivität mit human

Getestete Reaktivität human
In Publikationen genannte Reaktivitäthuman, Maus
Wirt / Isotyp Maus / IgG1
Klonalität Monoklonal
Typ Antikörper
Immunogen IRF3 fusion protein Ag27223
Vollständiger Name interferon regulatory factor 3
Berechnetes Molekulargewicht 47 kDa
Beobachtetes Molekulargewicht 50-60 kDa
GenBank-ZugangsnummerBC009395
Gene symbol IRF3
Gene ID (NCBI) 3661
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-G-Reinigung
Lagerungspuffer PBS with 0.02% sodium azide and 50% glycerol
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

The virul-induced expression of interferon(IFN) genes in infected cells implicate in the interplay of several constitutively expressed and virus-activated transcription factors. A family of IFN regulatory factors(IRFs) have been shown to has a role in the transcription of IFN genes as well as IFN-stimulated genes. IRF3 is a novel key transcriptional regulator of type I IFN-dependent immune responses and involves in the innate immune response against DNA and RNA viruses, by binding to the promoters of IFN. It located in the cytoplasm of uninfected cells in an inactive form, and following viral infection, double-stranded RNA (dsRNA), or toll-like receptor (TLR) signaling, could be phosphorylated by IKBKE and TBK1 kinases. This induces a conformational change, leading to its dimerization, nuclear localization and association with CREB binding protein (CREBBP) to form dsRNA-activated factor 1 (DRAF1), a complex which activates the transcription of the type I IFN and ISG genes.

Protokolle

PRODUKTSPEZIFISCHE PROTOKOLLE
WB protocol for IRF3 antibody 66670-1-IgProtokoll herunterladen
IHC protocol for IRF3 antibody 66670-1-IgProtokoll herunterladenl
STANDARD-PROTOKOLLE
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB,IF

Front Immunol

Swine Acute Diarrhea Syndrome Coronavirus Nucleocapsid Protein Antagonizes Interferon-β Production via Blocking the Interaction Between TRAF3 and TBK1.

Authors - Zhihai Zhou
humanWB

Vet Microbiol

DDX56 antagonizes IFN-β production to enhance EMCV replication by inhibiting IRF3 nuclear translocation

Authors - Shujuan Xu
humanWB

Heliyon

IDI1 inhibits the cGAS-Sting signaling pathway in hepatocellular carcinoma

Authors - Lin Fu
humanWB

Chin Herb Med

Anemoside B4 inhibits SARS-CoV-2 replication in vitro and in vivo

Authors - Mingyue Xiao
humanWB

Cell Rep

Nuclear translocation of cGAS orchestrates VEGF-A-mediated angiogenesis

Authors - Juanjuan Luo
humanWB

mSphere

Mammalian orthoreovirus capsid protein σ3 antagonizes RLR-mediated antiviral responses by degrading MAVS

Authors - Dianyu Li